Dr. Lal Path Labs · NSE: LALPATHLAB · BSE: 539524
Q3 FY24 results · Oct–Dec 2023
Dr. Lal Path Labs reported revenue from operations of ₹538.90 crore (up 10.1% from Q3 FY23) and net profit of ₹82.20 crore (up 53.4% from Q3 FY23) for Q3 FY24 (Oct–Dec 2023), on a consolidated basis.
| Item | Q3 FY24 | Q3 FY23 | YoY | Q2 FY24 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 538.90 | 489.40 | +10.1% | 601.30 | −10.4% |
| Other income | 18.30 | 10.50 | +74.3% | 18.10 | +1.1% |
| Total income | 557.20 | 499.90 | +11.5% | 619.40 | −10.0% |
| Profit before tax | 115.90 | 76.50 | +51.5% | 152.20 | −23.9% |
| Net profit for the period | 82.20 | 53.60 | +53.4% | 110.70 | −25.7% |
| Attributable to shareholders of the company | 81.30 | 52.80 | +54.0% | 109.30 | −25.6% |
| EPS, basic (₹) | 9.77 | 6.37 | +53.4% | 13.16 | −25.8% |
| Net margin (%) | 15.3 | 11.0 | 18.4 |
| Item | Q3 FY24 | Q3 FY23 | YoY | Q2 FY24 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 476.00 | 428.40 | +11.1% | 531.70 | −10.5% |
| Other income | 15.10 | 8.60 | +75.6% | 14.10 | +7.1% |
| Total income | 491.10 | 437.00 | +12.4% | 545.80 | −10.0% |
| Profit before tax | 119.50 | 84.10 | +42.1% | 150.90 | −20.8% |
| Net profit for the period | 88.30 | 62.40 | +41.5% | 113.00 | −21.9% |
| EPS, basic (₹) | 10.78 | 7.53 | +43.2% | 13.60 | −20.7% |
| Net margin (%) | 18.6 | 14.6 | 21.3 |
Consolidated
- Filed with BSE
- 02 Feb 2024, 12:40 IST
- Board meeting
- 01 Feb 2024
- Period
- 01 Oct 2023 to 31 Dec 2023
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 02 Feb 2024, 12:40 IST
- Board meeting
- 01 Feb 2024
- Period
- 01 Oct 2023 to 31 Dec 2023
- Review status
- Unaudited
- Source
- XBRL filing on BSE